References
- Hohl L, Soloway HB. Need prothrombin times and PTTs be run in duplicate?. Pathologist 1985; 39: 10–10
- Sage-El A, Burns E, Wenz B. The unwarranted use of replicate analysis in routine coagulation studies. Am J Clin Pathol 1985; 83: 81–83
- James P. Duplicate testing for PT/PTT: time for a change?. Diagnost Clin Test 1989; 27: 21–23
- Petinos P, Smith J. Performing routine PR/INR and aPTT singly or duplicate. RCPA Hematology QAP Additional exercise survey 9312. 1993
- Scheer WD, Catrou PG, Lipscomb GE, Boudreau DA. A comprehensive evaluation of the performance of duplicate prothrombin time and activated partial thromboplastin time assays. Am J Clin Pathol 1986; 85: 456–462
- Keshgegian A, Mann J, Cooper J. Is duplicate testing for prothrombin time and activated partial thromboplastin time necessary?. Arch Pathol Lab Med 1986; 110: 520–522
- Cornelison G, Rollins A, Santoro S. Duplicate coagulation assays warranted. Am J Clin Pathol 1985; 84: 261–262
- Koepke J, McLaren C, Wijetunga A, Houwen B. A method to examine the need for duplicate testing of common coagulation tests. Am J Clin Pathol 1994; 102: 242–247
- Bland M, Altman D. Statistical methods for assessing agreement between two methods of clinical measurement. The Lancet 1986; 1: 307–310
- Thom J, Stoner M, Miotti D, Nicol D. Evaluation of routine testing on the MLA 1000c fully automated coagulation analyser. Aust J Med Sci 1993; 14: 29–33
- Hirsch J, Dalen J, Deykin D, Poller L, Bussey H. Oral anticoagulants mechanism of action, clinical effectiveness and optimal therapeutic range. Chest 1995; 108(4)231–246, (sup)